Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Diversa Corporation (DVSA)

No earlier versions found for this Subject.

Return to Diversa Corporation (DVSA)

Company web page:
diversa.com

IPO filing:
hoovers.com

Diversa searches high and low to develop its DNA. In its quest for enzymes and biological compounds, Diversa collects and catalogs the DNA of organisms in diverse environments (from manure piles to industrial waste sites, from Antarctic valleys to tropical Costa Rica). Companies license these compounds to develop or improve their products, which include pesticides, detergents, oils, and pharmaceuticals. Diversa's first product is an enzyme for the oil and gas industry. Company partners include Novartis, Dow Chemical, Finnfeeds International, and a unit of what is now Aventis. Investment firms HealthCare Ventures and Patricof & Co. Ventures own 22% and 18% of Diversa, respectively.

-G